AI-Powered ECG could spot heart risks before cancer therapy begins
NCT ID NCT07515859
First seen Apr 20, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This completed study looked at whether an AI-enhanced electrocardiogram (ECG) can predict heart damage caused by cancer treatments like chemotherapy and immunotherapy. Researchers analyzed data from over 31,000 adults who had an ECG before starting cancer therapy. The goal was to see if this simple, low-cost tool could identify patients at higher risk for heart problems, helping doctors monitor and protect them better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
Conditions
Explore the condition pages connected to this study.